May 27, 2020
Kantum Pharma Highlights New Research Demonstrating Beneficial Effects of P2Y14 Antagonist in Acute Kidney Injury
May 20, 2020
HemaFlo Therapeutics Provides Update on Global Patent Portfolio
Apr 30, 2020
Global Acute Kidney Injury (AKI) Industry Assessment, 2017-2030: Market Size, Drivers & Barriers, Unmet Needs, Emerging Drugs, Market Share of Individual Therapies
Nov 26, 2019
Q BioMed Technology Partner Mannin Research Inc. Presents Data Showing Potential Treatment to Protect the Kidney in Acute Kidney Injury Using Mannin Tie2 Activator
Nov 04, 2019
Kantum Pharma Founder to Present Preclinical Data Demonstrating Beneficial Effects of P2Y14 Antagonist in Acute Kidney Injury at the American Society of Nephrology Annual Meeting
Sep 10, 2019
Aki Technologies' Second Annual "Aki Giving Moments" Campaign Promotes Charitable Giving for the Holidays
May 01, 2019
Praetego Initiates Clinical Development
Feb 14, 2019
Atox Bio Announces Appointment of Robert Greif as Chief Commercial Officer
Nov 05, 2018
Aki Technologies Launches Holiday Charity Campaign "Aki Giving Moments"
May 01, 2018
Ortho Clinical Diagnostics Supports ERAS® Cardiac Surgery Consensus Statement of Best Practices to Enhance Recovery After Heart Surgery
Jan 26, 2018
Astute Medical To Exhibit At Society Of Thoracic Surgeons Annual Meeting
Dec 27, 2017
Test For AKI Risk Assessment Could Lead To Safer ICU Care
Jul 27, 2017
Quark Pharmaceuticals Reports Positive Results from a Phase 2 Study to Evaluate the Efficacy and Safety of QPI-1002 for the Prevention of Acute Kidney Injury (AKI) in Subjects at High Risk of AKI Following Cardiac Surgery